Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Recruiting · NCT07629635 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, congenital heart disease, headache disorder, heart disorder, heart septal defect, hypnic headache, migraine disorder, nervous system disorder, patent foramen ovale | Recruiting | Phase 3 | 2026-10-08 | NCT07629635 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Columbia University | 375 |
| Occlutech International AB | 12 |
| W.L.Gore & Associates | 44 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Columbia University Irving Medical Center - NewYork Presbyterian Hospital (CUIMC/NYP) | New York | United States | 1 |